Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers

BACKGROUND: Neoadjuvant chemotherapy (NAC) is frequently used in gastrointestinal cancers (GIC), and pathological, radiological, and tumor marker responses are assessed during and after NAC. AIM: To evaluate the relationship between pathologic, radiologic, tumor marker responses and recurrence‐free...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhalla, Sheena, Zhu, Huili, Lin, Jung‐Yi, Özbek, Umut, Wilck, Eric J., Chang, Sanders, Chen, Xiuxu, Ward, Stephen, Harpaz, Noam, Polydorides, Alexandros D., Miller, William, Fiel, Maria Isabel, Modica, Ippolito, Fan, Wen, Zeizafoun, Nebras, Ang, Celina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714550/
https://www.ncbi.nlm.nih.gov/pubmed/34032391
http://dx.doi.org/10.1002/cnr2.1412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714550/
https://www.ncbi.nlm.nih.gov/pubmed/34032391
http://dx.doi.org/10.1002/cnr2.1412

Ejemplares similares